| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |